Publication | Closed Access

Neoadjuvant chemotherapy equalizes the optimal cytoreduction rate to primary surgery without improving survival in advanced ovarian cancer

Gynecologic SurgerySurgical OncologyGynecological SurgeryNeoadjuvant ChemotherapyOptimal Cytoreduction RateAdvanced Ovarian CancerMedicineGynecologySurgeryCancer TreatmentOncologyGynecology OncologyOvarian Cancer